126 related articles for article (PubMed ID: 10071234)
21. Immunohistochemical p53 overexpression correlated to c-erbB-2 and cathepsin D proteins in colorectal cancer.
Caruso ML; Valentini AM
Anticancer Res; 1996; 16(6B):3813-8. PubMed ID: 9042263
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women.
Talley L; Chhieng DC; Bell WC; Grizzle WE; Frost AR
Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671
[TBL] [Abstract][Full Text] [Related]
24. Morphogenesis of nonpolypoid colorectal adenomas and early carcinomas assessed by cell proliferation and apoptosis.
Nomura M; Watari J; Yokota K; Saitoh Y; Obara T; Kohgo Y
Virchows Arch; 2000 Jul; 437(1):17-24. PubMed ID: 10963375
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin D expression in colorectal adenocarcinomas and adenomas.
Kanber Y; Demirbag NR; Sam AD; Aydin N
Int J Biol Markers; 2002; 17(3):165-8. PubMed ID: 12408466
[TBL] [Abstract][Full Text] [Related]
26. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
Ioffe OB; Papadimitriou JC; Drachenberg CB
Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657
[TBL] [Abstract][Full Text] [Related]
27. Expression of CD40, CD44, bcl-2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma.
Sviatoha V; Rundgren A; Tani E; Hansson J; Kleina R; Skoog L
Cytopathology; 2002 Feb; 13(1):11-21. PubMed ID: 11985564
[TBL] [Abstract][Full Text] [Related]
28. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.
González-Vela MC; Garijo MF; Fernández F; Val-Bernal JF
Histol Histopathol; 2001 Apr; 16(2):399-406. PubMed ID: 11332695
[TBL] [Abstract][Full Text] [Related]
29. Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum.
Jackson PA; Green MA; Pouli A; Hubbard R; Marks CG; Cook MG
J Clin Pathol; 1995 Dec; 48(12):1098-101. PubMed ID: 8567994
[TBL] [Abstract][Full Text] [Related]
30. CD44 expression in benign and malignant colorectal polyps.
Neumayer R; Rosen HR; Reiner A; Sebesta C; Schmid A; Tüchler H; Schiessel R
Dis Colon Rectum; 1999 Jan; 42(1):50-5. PubMed ID: 10211520
[TBL] [Abstract][Full Text] [Related]
31. Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas.
Watson AJ; Merritt AJ; Jones LS; Askew JN; Anderson E; Becciolini A; Balzi M; Potten CS; Hickman JA
Br J Cancer; 1996 Apr; 73(8):889-95. PubMed ID: 8611422
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.
Tollenaar RA; van Krieken JH; van Slooten HJ; Bruinvels DJ; Nelemans KM; van den Broek LJ; Hermans J; van Dierendonck JH
Br J Cancer; 1998 Jun; 77(11):1842-7. PubMed ID: 9667656
[TBL] [Abstract][Full Text] [Related]
33. VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
Charpin C; Garcia S; Bergeret D; Andrac L; Horschowski N; Choux R; Lavaut MN
Br J Cancer; 1998 Jun; 77(12):2274-80. PubMed ID: 9649145
[TBL] [Abstract][Full Text] [Related]
34. The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors.
Vargas MP; Vargas HI; Kleiner DE; Merino MJ
Mod Pathol; 1997 Jan; 10(1):12-7. PubMed ID: 9021722
[TBL] [Abstract][Full Text] [Related]
35. Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases.
Kristek J; Dmitrović B; Kurbel S; Sakić K; Krajinović Z; Blazicević V; Has B; Marjanović K
Coll Antropol; 2007 Dec; 31(4):1043-7. PubMed ID: 18217456
[TBL] [Abstract][Full Text] [Related]
36. ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays.
Charpin C; Bergeret D; Garcia S; Andrac L; Martini F; Horschowski N; Choux R; Lavaut MN
Int J Oncol; 1998 May; 12(5):1041-8. PubMed ID: 9538126
[TBL] [Abstract][Full Text] [Related]
37. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
[TBL] [Abstract][Full Text] [Related]
38. Proliferation and apoptosis in proliferative lesions of the colon and rectum.
Kikuchi Y; Dinjens WN; Bosman FT
Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892
[TBL] [Abstract][Full Text] [Related]
39. Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia.
Saleh HA; Jackson H; Khatib G; Banerjee M
Pathol Oncol Res; 1999; 5(4):273-9. PubMed ID: 10607921
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of cathepsin D in correlation with extracellular matrix component, steroid receptor status and proliferative indices in breast cancer.
Ioachim E; Kamina S; Kontostolis M; Agnantis NJ
Virchows Arch; 1997 Nov; 431(5):311-6. PubMed ID: 9463571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
